Laurus Labs

Laurus Labs EBITDA per Share

The EBITDA per Share of Laurus Labs (LAURUSLABS.NS) as of Oct 13, 2026 is 24.00 INR. In the previous year, EBITDA per Share was 20.96 INR — a change of 14.53% (higher).

EBITDA per Share

24.00INR

YoY

14.53%

Last updated:

EBITDA per Share of Laurus Labs is 2026 24.00 INR. EBITDA per Share of Laurus Labs was 2025 20.96 INR. It decreases by 14.53% higher compared to the previous year.

The Laurus Labs EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2019
16.38 INR
Jan 1, 2020
10.60 INR
Jan 1, 2021
43.83 INR
Jan 1, 2022
44.53 INR
Jan 1, 2023
53.51 INR
Jan 1, 2024
14.78 INR
Jan 1, 2025
20.96 INR
Jan 1, 2026
24.00 INR
The Laurus Labs EBITDA per Share history
YEAREBITDA per ShareYoY
24.00INR+14.53%
20.96INR+41.78%
14.78INR-72.38%
53.51INR+20.18%
44.53INR+1.59%
43.83INR+313.50%
10.60INR-35.30%
16.38INR+5.60%
15.51INR+8.17%
14.34INR+11.74%
12.84INR+227.46%
3.92INR+15.60%
3.39INR—
Access this data via the Eulerpool API
Get Free API Key

Laurus Labs Stock analysis

What does Laurus Labs do? Laurus Labs Ltd is an Indian pharmaceutical company specializing in the production of active pharmaceutical ingredients for generics and innovative drugs. Since its establishment in 2005, the company has become one of the leading providers of API products on the global market. Answer: Laurus Labs Ltd is an Indian pharmaceutical company specializing in the production of active pharmaceutical ingredients for generics and innovative drugs. Laurus Labs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Laurus Labs stock

EBITDA per Share of Laurus Labs is 24.00 INR in 2026.

EBITDA per Share of Laurus Labs changed from 20.96 INR to 24.00 INR, representing a 14.53% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Laurus Labs since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Laurus Labs

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Laurus Labs